Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and emerging targeted systemic therapies: a new era for atopic dermatitis
Dylan E. Lee, Ashley K. Clark, Khiem A. Tran, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 4, pp. 364-374
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
Yael Renert‐Yuval, Emma Guttman‐Yassky
Annals of Allergy Asthma & Immunology (2019) Vol. 124, Iss. 1, pp. 28-35
Closed Access | Times Cited: 117
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Ana B. Pavel, Teresa Song, Hyun Je Kim, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 144, Iss. 4, pp. 1011-1024
Open Access | Times Cited: 110
Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation
Tian H. Zhu, Tian Zhu, Khiem A. Tran, et al.
British Journal of Dermatology (2018) Vol. 179, Iss. 3, pp. 570-581
Closed Access | Times Cited: 108
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
Celina Dubin, Ester Del Duca, Emma Guttman‐Yassky
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 8, pp. 835-852
Closed Access | Times Cited: 59
Oral Janus kinase inhibitors for atopic dermatitis
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 35
Unraveling Atopic Dermatitis: Insights into Pathophysiology, Therapeutic Advances, and Future Perspectives
Ashutosh Pareek, Lipika Kumari, Aaushi Pareek, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 425-425
Open Access | Times Cited: 12
Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
Lina U. Ivert, Carl‐Fredrik Wahlgren, Lina U. Ivert, et al.
Acta Dermato Venereologica (2019) Vol. 99, Iss. 4, pp. 375-378
Open Access | Times Cited: 65
Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases
Thomas Litman
Apmis (2019) Vol. 127, Iss. 5, pp. 386-424
Open Access | Times Cited: 64
A comparison of international management guidelines for atopic dermatitis
Lindsey M. LePoidevin, Dylan E. Lee, Vivian Y. Shi
Pediatric Dermatology (2018) Vol. 36, Iss. 1, pp. 36-65
Open Access | Times Cited: 55
Similarities and differences in peripheral itch and pain pathways in atopic dermatitis
Gil Yosipovitch, Brian Kim, Thomas A. Luger, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 904-912
Open Access | Times Cited: 13
Current and emerging therapies for hand eczema
Griffin R. Lee, Melody Maarouf, Aleksi K. Hendricks, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 3
Open Access | Times Cited: 42
Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology
Valéria Aoki, Daniel Lorenzini, Raquel Leão Orfali, et al.
Anais Brasileiros de Dermatologia (2019) Vol. 94, Iss. 2 suppl 1, pp. 67-75
Open Access | Times Cited: 39
<p>Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis</p>
Tiffany Y. Loh, Jennifer L. Hsiao, Vivian Y. Shi
Journal of Asthma and Allergy (2020) Vol. Volume 13, pp. 109-114
Open Access | Times Cited: 38
PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
Yuval Ramot, Marta Bertolini, M. Boboljova, et al.
Experimental Dermatology (2019) Vol. 29, Iss. 3, pp. 312-321
Open Access | Times Cited: 37
Ocular surface disease associated with dupilumab treatment for atopic diseases
Canan Aslı Utine, Gavin Li, Penny A. Asbell, et al.
The Ocular Surface (2020) Vol. 19, pp. 151-156
Closed Access | Times Cited: 37
Paeonol inhibits the development of 1‑chloro‑2,4‑dinitrobenzene‑induced atopic dermatitis via mast and T cells in BALB/c mice
Yujiao Meng, Zhengrong Liu, Chunyan Zhai, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 32
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
Celina Dubin, Ester Del Duca, Emma Guttman‐Yassky
Therapeutics and Clinical Risk Management (2020) Vol. Volume 16, pp. 1319-1332
Open Access | Times Cited: 32
A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice:
Maria C. Schneeweiss, Robert J. Glynn, Richard Wyss, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 3
Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies
Chia‐Yu Chu
Clinical Reviews in Allergy & Immunology (2020) Vol. 61, Iss. 2, pp. 114-127
Closed Access | Times Cited: 27
Immune mediators and therapies for pruritus in atopic dermatitis and psoriasis
Sebastian Yu, Yanxi Li, Yan Zhou, et al.
Journal of Cutaneous Immunology and Allergy (2019) Vol. 2, Iss. 1, pp. 4-14
Open Access | Times Cited: 26
Comparative safety of systemic immunomodulatory medications in adults with atopic dermatitis
Maria C. Schneeweiss, Lourdes M. Pérez-Chada, Joseph F. Merola
Journal of the American Academy of Dermatology (2019) Vol. 85, Iss. 2, pp. 321-329
Closed Access | Times Cited: 26
Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns
C. Elise Kleyn, S. Barbarot, Catherine Reed, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1947-1965
Open Access | Times Cited: 14
Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis
Aleksi J. Hendricks, Peter Lio, Vivian Y. Shi
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 4, pp. 565-569
Closed Access | Times Cited: 23
Racial and ethnic disparities in global atopic dermatitis clinical trials
Kyla N. Price, Jeffrey M. Krase, Tiffany Y. Loh, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 2, pp. 378-380
Closed Access | Times Cited: 22
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
Gurbir Dhadwal, Lorne Albrecht, Robert Gniadecki, et al.
Journal of Cutaneous Medicine and Surgery (2018) Vol. 22, Iss. 1_suppl, pp. 21S-29S
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top